BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29326043)

  • 1. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
    Zhang Z; Shen M; Zhou G
    Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
    Huang Z; Zhang S; Du J; Zhang X; Zhang W; Huang Z; Ouyang P
    Med Sci Monit; 2020 Aug; 26():e923664. PubMed ID: 32759885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.
    Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
    Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
    J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
    Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
    EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
    Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
    Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
    Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
    Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
    Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma.
    Hou S; Chen X; Li M; Huang X; Liao H; Tian B
    Aging (Albany NY); 2020 Jul; 12(14):14542-14555. PubMed ID: 32694239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.
    Huang X; Huang Y; Lv Z; Wang T; Feng H; Wang H; Du S; Wu S; Shen D; Wang C; Li H; Wang B; Ma X; Zhang X
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
    Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
    Tian Y; Wu J; Chagas C; Du Y; Lyu H; He Y; Qi S; Peng Y; Hu J
    BMC Cancer; 2018 Nov; 18(1):1187. PubMed ID: 30497429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.
    Xu TP; Wang YF; Xiong WL; Ma P; Wang WY; Chen WM; Huang MD; Xia R; Wang R; Zhang EB; Liu YW; De W; Shu YQ
    Cell Death Dis; 2017 Jun; 8(6):e2837. PubMed ID: 28569791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of triosephosphate isomerase and downstream functional genes on gastric cancer.
    Chen T; Huang Z; Tian Y; Wang H; Ouyang P; Chen H; Wu L; Lin B; He R
    Oncol Rep; 2017 Sep; 38(3):1822-1832. PubMed ID: 28737830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non-small cell lung cancer cells via p53-p21 signaling pathway.
    Shen W; Tong D; Chen J; Li H; Hu Z; Xu S; He S; Ge Z; Zhang J; Mao Q; Chen H; Xu G
    J Clin Lab Anal; 2022 May; 36(5):e24396. PubMed ID: 35373420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
    Chong Y; Xue L
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):29-40. PubMed ID: 33639053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
    Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
    J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC.
    Zhang Y; Peng Z; Zhao Y; Chen L
    Med Sci Monit; 2016 Apr; 22():1415-20. PubMed ID: 27120728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.